Amedeo Smart

Free Medical Literature Service



Bladder Cancer

  Free Subscription


1 Am J Clin Nutr
1 Biosens Bioelectron
11 BJU Int
2 Can J Urol
1 Cancer Epidemiol Biomarkers Prev
1 Environ Int
1 Eur Urol
1 Expert Rev Anticancer Ther
1 Expert Rev Mol Diagn
1 Hum Cell
1 Int J Clin Oncol
2 J Endourol
1 J Hum Genet
1 J Urol
1 Mol Clin Oncol
1 Mol Med Rep
2 Neoplasma
1 Oncogene
1 Oncol Lett
1 Oncotarget
1 Open Access Maced J Med Sci
1 Pathol Oncol Res
1 Radiographics
4 Urol Oncol
1 Virchows Arch

    Am J Clin Nutr

  1. TU H, Dinney CP, Ye Y, Grossman HB, et al
    Is folic acid safe for non-muscle-invasive bladder cancer patients? An evidence-based cohort study.
    Am J Clin Nutr. 2018;107:208-216.
    >> Share

    Biosens Bioelectron

  2. MACGREGOR-RAMIASA M, McNicholas K, Ostrikov K, Li J, et al
    A platform for selective immuno-capture of cancer cells from urine.
    Biosens Bioelectron. 2017;96:373-380.
    >> Share

    BJU Int

    NICE guidance and the BJUI.
    BJU Int. 2017;120:743.
    >> Share

    Human development and its impact on genitourinary cancers.
    BJU Int. 2017;120:747-748.
    >> Share

    Cystectomy for cT4 prostate cancer: the most radical treatment.
    BJU Int. 2017;120.
    >> Share

  6. PERERA M, Papa N, Christidis D, McGrath S, et al
    The impact of the global bacille Calmette-Guerin shortage on treatment patterns: population-based data.
    BJU Int. 2018;121:169-172.
    >> Share

  7. MOSSANEN M, Krasnow RE, Lipsitz SR, Preston MA, et al
    Associations of specific postoperative complications with costs after radical cystectomy.
    BJU Int. 2018;121:428-436.
    >> Share

  8. GUO RQ, Hong P, Xiong GY, Zhang L, et al
    Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis.
    BJU Int. 2018;121:184-193.
    >> Share

  9. KOCH MO
    Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.
    BJU Int. 2017;119:816.
    >> Share

    Speeding up recovery from radical cystectomy: how low can we go?
    BJU Int. 2017;120:162-163.
    >> Share

  11. VON LANDENBERG N, Speed JM, Trinh QD
    Do micropapillary patients benefit from chemotherapy?
    BJU Int. 2017;119:656-658.
    >> Share

  12. DAVIS JW
    Biomarker classification, validation, and what to look for in 2017 and beyond.
    BJU Int. 2017;119:812-814.
    >> Share

  13. MINERVINI A, Vanacore D, Vittori G, Milanesi M, et al
    Florence robotic intracorporeal neobladder (FloRIN): a new reconfiguration strategy developed following the IDEAL guidelines.
    BJU Int. 2018;121:313-317.
    >> Share

    Can J Urol

  14. JUE JS, Koru-Sengul T, Moore KJ, Miao F, et al
    Sociodemographic and survival disparities for histologic variants of bladder cancer.
    Can J Urol. 2018;25:9179-9185.
    >> Share

  15. MANACH Q, Cussenot O, Roupret M, Game X, et al
    Analysis of bladder cancer subtypes in neurogenic bladder tumors.
    Can J Urol. 2018;25:9161-9167.
    >> Share

    Cancer Epidemiol Biomarkers Prev

  16. JORDAHL KM, Randolph TW, Song X, Sather CL, et al
    Genome-wide DNA methylation in pre-diagnostic blood and bladder cancer risk in the Women's Health Initiative.
    Cancer Epidemiol Biomarkers Prev. 2018 Mar 14. pii: 1055-9965.EPI-17-0951.
    >> Share

    Environ Int

  17. SAINT-JACQUES N, Brown P, Nauta L, Boxall J, et al
    Estimating the risk of bladder and kidney cancer from exposure to low-levels of arsenic in drinking water, Nova Scotia, Canada.
    Environ Int. 2018;110:95-104.
    >> Share

    Eur Urol

  18. CUMBERBATCH MGK, Foerster B, Catto JWF, Kamat AM, et al
    Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.
    Eur Urol. 2018 Mar 6. pii: S0302-2838(18)30121.
    >> Share

    Expert Rev Anticancer Ther

  19. OOSTERLINCK W, Decaestecker K
    Update on early instillation of chemotherapy after transurethral resection of non-muscle-invasive bladder cancer.
    Expert Rev Anticancer Ther. 2018 Mar 15:1-7. doi: 10.1080/14737140.2018.1451748.
    >> Share

    Expert Rev Mol Diagn

  20. ILIJAZI D, Abufaraj M, Hassler MR, Ertl IE, et al
    Waiting in the wings: the emerging role of molecular biomarkers in bladder cancer.
    Expert Rev Mol Diagn. 2018 Mar 15. doi: 10.1080/14737159.2018.1453808.
    >> Share

    Hum Cell

  21. JI D, Jiang L, Li Y
    MiR-192-5p suppresses the growth of bladder cancer cells via targeting Yin Yang 1.
    Hum Cell. 2018 Mar 13. pii: 10.1007/s13577-018-0201.
    >> Share

    Int J Clin Oncol

  22. NAZARI A, Khorramdelazad H, Hassanshahi G
    Correction to: Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
    Int J Clin Oncol. 2018 Mar 10. pii: 10.1007/s10147-018-1257.
    >> Share

    J Endourol

  23. MADEC FX, Hedhli O, Perrouin-Verbe MA, Levesque A, et al
    Feasibility, Morbidity, and Functional Results of Supratrigonal Cystectomy with Augmentation Ileocystoplasty by Combined Robot-Assisted Laparoscopy and Mini-Laparotomy Approach.
    J Endourol. 2017;31:655-660.
    >> Share

  24. PLANELLES GOMEZ J, Olmos Sanchez L, Cardosa Benet JJ, Martinez Lopez E, et al
    Holmium YAG Photocoagulation: Safe and Economical Alternative to Transurethral Resection in Small Nonmuscle-Invasive Bladder Tumors.
    J Endourol. 2017;31:674-678.
    >> Share

    J Hum Genet

  25. SUGAWARA S, Yamada Y, Arai T, Okato A, et al
    Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
    J Hum Genet. 2018 Mar 14. pii: 10.1038/s10038-018-0437.
    >> Share

    J Urol

  26. PERLIS N, Krahn MD, Boehme KE, Alibhai SM, et al
    The Bladder Utility Symptom Scale (BUSS): A Novel Patient-Reported Outcome Instrument in Bladder Cancer.
    J Urol. 2018 Mar 9. pii: S0022-5347(18)42498-6. doi: 10.1016/j.juro.2018.
    >> Share

    Mol Clin Oncol

  27. HUANG J, Ma X, Zhang L, Jia H, et al
    Diagnostic accuracy of optical coherence tomography in bladder cancer patients: A systematic review and meta-analysis.
    Mol Clin Oncol. 2018;8:609-612.
    >> Share

    Mol Med Rep

  28. TANG F, He Z, Lei H, Chen Y, et al
    Identification of differentially expressed genes and biological pathways in bladder cancer.
    Mol Med Rep. 2018 Mar 9. doi: 10.3892/mmr.2018.8711.
    >> Share


  29. STANIK M, Poprach A, Macik D, Capak I, et al
    Clinically node-positive bladder cancer: oncological results of induction chemotherapy and consolidative surgery.
    Neoplasma. 2018;65:287-291.
    >> Share

  30. KOLLARIK B, Zvarik M, Bujdak P, Weibl P, et al
    Urinary fluorescence analysis in diagnosis of bladder cancer.
    Neoplasma. 2018;65:234-241.
    >> Share


  31. SHEN P, Jing Y, Zhang R, Cai MC, et al
    Comprehensive genomic profiling of neuroendocrine bladder cancer pinpoints molecular origin and potential therapeutics.
    Oncogene. 2018 Mar 14. pii: 10.1038/s41388-018-0192.
    >> Share

    Oncol Lett

  32. FENG Z, Wang B
    Long non-coding RNA HNF1A-AS1 promotes cell viability and migration in human bladder cancer.
    Oncol Lett. 2018;15:4535-4540.
    >> Share


  33. YOSHIDA T, Sopko NA, Kates M, Liu X, et al
    Three-dimensional organoid culture reveals involvement of Wnt/beta-catenin pathway in proliferation of bladder cancer cells.
    Oncotarget. 2018;9:11060-11070.
    >> Share

    Open Access Maced J Med Sci

  34. WARLI SM, Kadar DD, Siregar GP
    Ki-67 Expression as a Predictive Factor of Muscle Invasion in Bladder Cancer.
    Open Access Maced J Med Sci. 2018;6:260-262.
    >> Share

    Pathol Oncol Res

  35. DA SILVA JNL, Ranzi AD, Carvalho CT, Scheide TV, et al
    Cell Cycle Markers in the Evaluation of Bladder Cancer.
    Pathol Oncol Res. 2018 Mar 9. pii: 10.1007/s12253-018-0389.
    >> Share


  36. SHELMERDINE SC, Lorenzo AJ, Gupta AA, Chavhan GB, et al
    Pearls and Pitfalls in Diagnosing Pediatric Urinary Bladder Masses.
    Radiographics. 2017;37:1872-1891.
    >> Share

    Urol Oncol

  37. MOSCHINI M, Shariat SF, Abufaraj M, Soria F, et al
    The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes.
    Urol Oncol. 2017;35:151.
    >> Share

  38. DU E, Zhang C, Qin Z, Yang K, et al
    Low expression of TMEM67 is a critical predictor of poor prognosis in human urothelial carcinoma of the bladder.
    Urol Oncol. 2017;35:152.
    >> Share

  39. NIWA N, Kikuchi E, Matsumoto K, Kosaka T, et al
    Does switching the bacillus Calmette-Guerin strain affect clinical outcome in patients with recurrent non-muscle-invasive bladder cancer after initial bacillus Calmette-Guerin therapy?
    Urol Oncol. 2018 Mar 9. pii: S1078-1439(18)30045.
    >> Share

  40. AZEVEDO R, Soares J, Peixoto A, Cotton S, et al
    Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology.
    Urol Oncol. 2018 Mar 9. pii: S1078-1439(18)30044.
    >> Share

    Virchows Arch

  41. SANTI R, Cai T, Nobili S, Galli IC, et al
    Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study.
    Virchows Arch. 2018 Mar 10. pii: 10.1007/s00428-018-2310.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016